Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB2 vs Remicade in Rheumatoid Arthritis
NCT01936181Phase 3Completed
- Sponsor
- Samsung Bioepis
- Start
- Aug 2013
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of SB2 in rheumatoid arthritis (RA), sponsored by Samsung Bioepis. Started Aug 2013; status: completed.
02
Drugs
SB2
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01936181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936181.